Revenue
2020
2021
2022
2023
2024
2025
Aligos Therapeutics, Inc. (ALGS)
Price$5.27Cached quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $2.2M | $3.6M | $6.2M | $0 | $0 | $0 | — |
| Research & development | $69.5M | $70.3M | $73.0M | $85.1M | $104.2M | $79.9M | $44.0M |
| Operating expenses | $90.2M | $93.1M | $103.7M | $111.5M | $132.7M | $97.8M | $54.0M |
| Operating income | −$88.0M | −$89.2M | −$88.1M | −$97.6M | −$128.3M | −$97.8M | −$54.0M |
| Operating margin | −4,024.93% | −2,468.96% | −1,423.47% | — | — | — | — |
| EBITDA | −$87.1M | −$88.1M | −$86.6M | −$95.3M | −$125.3M | −$95.1M | −$52.6M |
| EBITDA margin | −3,982.39% | −2,440.52% | −1,398.29% | — | — | — | — |
| Net income | −$24.2M | −$131.2M | −$87.7M | −$96.0M | −$128.3M | −$108.5M | −$52.3M |
| Net profit margin | −1,106.72% | −3,633.65% | −1,416.23% | — | — | — | — |
| Basic EPSper basic share | -$2.45 | -$20.94 | -$34.20 | -$56.25 | -$80.50 | -$271.75 | -$651.00 |
| Diluted EPSper diluted share | -$2.45 | -$20.94 | -$34.20 | -$56.25 | -$80.50 | -$271.75 | -$651.00 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Deep Track Capital, LP | 444.11K |
Alyeska Investment Group, L.P. | 412K |
Sio Capital Management, LLC | 327.24K |
MARSHALL WACE, LLP | 246.58K |
Woodline Partners LP | 177.36K |
VANGUARD CAPITAL MANAGEMENT LLC | 175.54K |
BAKER BROS. ADVISORS LP | 83.06K |
HHLR ADVISORS, LTD. | 76.25K |
D. E. Shaw & Co., Inc. | 66.46K |
UBS Group AG | 59.99K |
GEODE CAPITAL MANAGEMENT, LLC | 47.17K |
JANE STREET GROUP, LLC | 32.4K |
BlackRock, Inc. | 30.29K |
VANGUARD FIDUCIARY TRUST CO | 28.61K |
DIMENSIONAL FUND ADVISORS LP | 21.04K |
Verition Fund Management LLC | 18.89K |
Trexquant Investment LP | 12.34K |
RENAISSANCE TECHNOLOGIES LLC | 10.8K |
Rockefeller Capital Management L.P. | 10K |
Federation des caisses Desjardins du Quebec | 4.65K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data